MD - Pediatrix Medical Group, Inc.
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $0.38
|
Rev Est: $468.1M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$20.67
DETAILS
HIGH:
$22.00
LOW:
$19.00
MEDIAN:
$21.00
CONSENSUS:
$20.67
UPSIDE:
3.04%
Market Cap:
1.72B
Volume:
1,073,302
Avg Volume:
773,616
52 Week Range:
11.84-24.99
Sector:
Healthcare
Industry:
Medical - Care Facilities
Beta:
0.78
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
4,120
IPO Date:
1995-09-20
EPS (TTM):
1.94
P/E Ratio:
11.03
Revenue (TTM):
1.91B
Total Assets:
2.25B
Total Debt:
634.62M
Cash & Equiv:
375.24M
Rev Growth (5Y):
2.0%
EPS Growth (5Y):
-6.3%
FCF Growth (5Y):
7.5%
ROCE:
12.9%
Debt/Equity:
0.73
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-19 | $0.50 | $0.53 | -5.7% | $493.8M | $469.4M | +5.2% |
| 2025-11-03 | $0.67 | $0.46 | +45.7% | $492.9M | $486.2M | +1.4% |
| 2025-08-05 | $0.53 | $0.42 | +26.2% | $468.8M | $473.7M | -1.0% |
| 2025-05-06 | $0.33 | $0.25 | +32.0% | $458.4M | $459.7M | -0.3% |
| 2025-02-20 | $0.51 | $0.37 | +37.8% | $502.4M | $473.3M | +6.1% |
| 2024-11-01 | $0.44 | $0.37 | +18.9% | $511.2M | $487.1M | +4.9% |
| 2024-08-06 | $0.34 | $0.31 | +9.7% | $504.3M | $505.5M | -0.2% |
| 2024-05-07 | $0.20 | $0.18 | +11.1% | $495.1M | $499.1M | -0.8% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.91B | 2.01B | 1.99B | 1.97B | 1.91B | 1.73B | 1.78B | 3.65B | 3.46B | 3.18B | 2.78B | 2.44B |
| Net Income | 165.39M | (99.07M) | (60.41M) | 66.33M | 130.96M | (796.49M) | (1.50B) | 268.63M | 320.37M | 324.91M | 336.32M | 317.28M |
| EPS | 1.94 | -1.19 | -0.72 | 0.80 | 1.52 | -9.31 | -17.78 | 2.95 | 3.42 | 3.47 | 3.59 | 3.30 |
| Total Assets | 2.25B | 2.15B | 2.22B | 2.35B | 2.72B | 3.35B | 4.15B | 5.93B | 5.87B | 5.34B | 4.55B | 3.61B |
| Total Debt | 634.62M | 662.31M | 701.65M | 717.08M | 1.07B | 1.80B | 1.79B | 1.97B | 1.85B | 1.71B | 1.27B | 569.32M |
| Cash & Equivalents | 375.24M | 229.94M | 73.26M | 9.82M | 387.39M | 1.12B | 107.87M | 36.74M | 60.20M | 55.70M | 51.57M | 47.93M |
| Operating Cash Flow | 271.09M | 206.57M | 137.32M | 166.94M | 76.74M | 204.62M | 357.71M | 289.93M | 511.38M | 443.78M | 368.70M | 422.64M |
| Free Cash Flow | 252.63M | 184.55M | 104.00M | 137.23M | 44.49M | 175.83M | 338.44M | 241.06M | 462.07M | 404.51M | 341.63M | 404.58M |
| FCF per Share | 2.96 | 2.21 | 1.24 | 1.65 | 0.51 | 2.05 | 4.02 | 2.65 | 5.00 | 4.38 | 3.64 | 4.21 |
| Book Value | 865.85M | 764.94M | 849.06M | 891.63M | 896.49M | 747.49M | 1.50B | 3.09B | 3.07B | 2.76B | 2.44B | 2.27B |
| Cash & ST Investments | 499.72M | 348.51M | 177.74M | 103.06M | 487.11M | 1.23B | 182.38M | 58.67M | 70.49M | 66.98M | 60.42M | 53.96M |
| ROC Equity | 0.19 | -0.13 | -0.07 | 0.07 | 0.15 | -1.07 | -1.00 | 0.09 | 0.10 | 0.12 | 0.14 | 0.14 |